Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Wake Forest University Health Sciences
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03998202
This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.
Condition
Colorectal Cancer, Sarcopenia
Investigators
Grant R Williams, MD, Gregory A. Masters, Bryan A. Faller, Thomas E. Lad, Suparna Mantha, Jay W. Carlson, Deborah W. Wilbur, Robert J. Behrens, Raed Al-Rajabi, Philip J. Stella, Kathleen J. Yost, Preston D. Steen, Pamala A. Pawloski, Glenn J. Lesser, Timothy D. Moore, Howard M. Gross, Raghava Reddy Levaka Veera, Jeffrey K. Giguere, James D. Bearden, Anthony J. Jaslowski, Marcus S. Noel, James E. Radford, Demet Gokalp Yasar, Mindie M. Kavanaugh, Grant R Williams, Jay W Carlson, Gregory A Masters, Tareq Al Baghdadi, Bryan A Faller, Joshua Lukenbill, Deborah W Wilbur, Kathleen J Yost, Timothy D Moore, Howard M Gross, Glenn J Lesser, Site Public Contact, None, Tareq Al baghdadi, David T Moore, William P Fusselman, Bret EB Friday

See list of participating sites